Franco Zunino

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Paola Perego, Monica Giarola, Sabina Carla Righetti et al. · PubMed · 1996 · 392 citations

P53 Status, Reduced Bax Expression, Pathology +16

Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents

Federica Belluti, Gabriele Fontana, Laura Dal Bo et al. · Bioorganic & Medicinal Chemistry · 2010 · 230 citations

Combinatorial Chemistry, Medicinal Chemistry, Anticancer Activities +9

New Cisplatin Analogues—On the Way to Better Antitumor Agents

Alessandro Pasini, Franco Zunino · Angewandte Chemie International Edition in English · 1987 · 198 citations

Molecular Pharmacology, Medicinal Chemistry, Clinical Success +15

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

Franco Zunino, Graziella Pratesi, Antonella Micheloni et al. · Chemico-Biological Interactions · 1989 · 157 citations

Urology, Chemoprevention Strategy, Medicine +8

p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma

Cinzia Lavarino, Silvana Pilotti, Maria Oggionni et al. · Journal of Clinical Oncology · 2000 · 149 citations